Pharma

Your Article Summary

See Latest Articles

Wellcome Trust and Merck Launch First of Its Kind Joint Venture to Develop Affordable Vaccines for Low-Income Countries
Merck & Co., 09/18/09

The Wellcome Trust and Merck & Co., Inc. announced the creation of the MSD Wellcome Trust Hilleman Laboratories, the first of its kind research and development joint venture with a not–for–profit mission to focus on developing affordable vaccines to prevent diseases that commonly affect low–income countries. The joint venture marks the first time a research charity and a pharmaceutical company have partnered to form a separate entity with equally shared funding and decision–making rights.

Today in Medical Devices/Products...keeping you current

Receive free subspecialty "5-minute updates" via email

FDA Advisory Panel Unanimously Recommends Expanded Indication for Boston Scientifics Heart Failure Devices Based on Landmark MADIT-CRT Trial
Boston Scientific, 03/19/10

Lubricious coatings from Bayer MaterialScience
BayNews International, 03/19/10

Bayer MaterialScience develops drug-releasing coatings for medical applications
BayNews International, 03/19/10

 See all of Medical Devices/Products

Today in Research & Development...keeping you current

Receive free subspecialty "5-minute updates" via email

Bayer MaterialScience develops drug-releasing coatings for medical applications
BayNews International, 03/19/10

First Publication of Data from Pivotal Clinical Trial for Medtronic Deep Brain Stimulation Therapy for Epilepsy Published Today in Epilepsia
Medtronic, 03/19/10

CEL-SCI Completes Validation Of Manufacturing Facility Allowing It To Commence Manufacturing Of Multikine
CEL-SCI, 03/19/10

 See all of Research & Development